There are no SU2C funding opportunities at this time. Please continue to monitor this website for future opportunities.
Since its launch in 2008, Stand Up To Cancer (SU2C) has funded a total of seven Dream Teams and 26 Innovative Research Grants, totaling $109 million. These grants encompass 336 scientists at 68 institutions conducting more than 30 clinical trials.
On May 28, 2009, one year after its launch, SU2C announced funding of five multi-institutional, cross-disciplinary, three-year “Dream Team” grants, totaling $73.6 million. Since then, in December 2011, and in April 2012, two new Dream Teams were announced. The jointly funded grants provided $6 million and $10 million to translational research focusing on melanoma and prostate cancer, respectively.
In addition, through its Innovative Research Grants, SU2C has made an effort to support the next generation of extraordinary leaders in their quest to conquer cancer. These grants provide up to $750,000, over a three-year term, to early-career scientists whose novel, high-risk, high-reward research proposals may have significant potential for translational application. Thirteen grants were awarded in 2009, and 13 more in 2011 totaling $19.4 million.